El-Nile Co. for Pharmaceuticals & Chemical Industries (NIPH) Key Statistics
26 reported figures for El-Nile Co. for Pharmaceuticals & Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 12.72B
- P/E (trailing)
- 40.88
- P/B
- 15.43
- Dividend yield (FY 2025)
- 0.79%
Income (latest fiscal year)
- Revenue
- EGP 1.29B
- Net income
- EGP 125.73M
- EBITDA
- EGP 374.19M
- Free cash flow
- EGP -472.82M
- Profit margin
- 9.75%
Balance sheet
- Total assets
- EGP 2.32B
- Total debt
- EGP 1.35B
- Book value
- EGP 1.1B
Growth
- Revenue growth
- 12.87%
- Profit growth
- 39.34%
- EPS growth
- 18.21%
Per share
- EPS (fiscal year)
- 2.79
- Book value per share
- 22.07
- Dividend per share
- 2
- Return on equity
- 20.75%
- Return on assets
- 6.63%
Technical
- RSI (14)
- 41.6
- 50-day moving average
- EGP 316.18
- 200-day moving average
- EGP 191.32
- Beta (1Y)
- 1
Shares
- Shares outstanding
- 50M
- Free float
- 28.33%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.